首页> 外文OA文献 >Efficacy and safety of levetiracetam as adjunctive treatment of refractory partial seizures in a multicentre open-label single-arm trial in Korean patients

【2h】

Efficacy and safety of levetiracetam as adjunctive treatment of refractory partial seizures in a multicentre open-label single-arm trial in Korean patients

机译：左乙拉西坦在韩国多中心开放标签单臂试验中作为难治性部分性发作的辅助治疗的有效性和安全性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Heo Kyoung; Lee Byung In; Yi Sang Do; Huh Kyoon; Kim Jae Moon; Lee Sang Ahm; Shin Dong Jin; Song Hong Ki; Lee Sang Kun; Kim Jeong Yeon; Lu Sarah; Dubois Cécilia; Tonner Françoise;
展开▼
作者单位

展开▼
年度 2007
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Efficacy and safety of levetiracetam as adjunctive treatment of refractory partial seizures in a multicentre open-label single-arm trial in Korean patients. [J] . Heo K, Lee BI, Yi SD, Seizure: the journal of the British Epilepsy Association . 2007,第5期

机译：在多中心开放标签单臂试验中，左乙拉西坦作为难治性部分性癫痫的辅助治疗的有效性和安全性。
2. Short-term efficacy and safety of zonisamide as adjunctive treatment for refractory partial seizures: A multicenter open-label single-arm trial in Korean patients [J] . HeoK., LeeB.I., YiS.D., Seizure: the journal of the British Epilepsy Association . 2012,第3期

机译：唑尼沙胺辅助治疗难治性部分性癫痫的近期疗效和安全性：一项针对韩国患者的多中心开放标签单臂试验
3. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study. [J] . Beran RG, Berkovic SF, Black AB, Epilepsy research . 2005,第1期

机译：左乙拉西坦1000-3000 mg /天对难治性部分发作的患者的疗效和安全性：一项多中心，开放标签的单臂研究。
4. Study of Efficacy and Safety of Willow Bark Extract (Assalix) in Treatment of Chronic Low Back Pain in Patients of Different Age with Osteochondrosis [C] . V.V. Povoroznyuk, T.A. Karasevskaya International Pain Clinic Congress . 2008

机译：柳树皮提取物（Assalix）治疗不同年龄患者慢性低腰疼痛的疗效和安全性研究
5. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
6. Efficacy and safety of extended-release oxcarbazepine (Oxtellar XR™) as adjunctive therapy in patients with refractory partial-onset seizures: a randomized controlled trial [O] . JA French, P Baroldi, ST Brittain, -1

机译：缓释奥卡西平（Oxtellar XR™）作为难治性部分发作的辅助治疗的疗效和安全性：一项随机对照试验
7. Short-term efficacy and safety of zonisamide as adjunctive treatment for refractory partial seizures: A multicenter open-label single-arm trial in Korean patients [O] . Heo Kyoung, Lee Byung In, Yi Sang Do, 2012

机译：唑尼沙胺作为难治性部分性癫痫的辅助治疗的近期疗效和安全性：韩国患者的多中心开放标签单臂试验

Efficacy and safety of levetiracetam as adjunctive treatment of refractory partial seizures in a multicentre open-label single-arm trial in Korean patients

著录项

相似文献

相关主题

期刊订阅